Short Interest in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Increases By 87.1%

Posted by Brian Himes on Jun 16th, 2026

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 2,211,305 shares, a growth of 87.1% from the May 14th total of 1,182,112 shares. Currently, 0.4% of the shares of the company are sold short. Based on an average trading volume of 876,548 shares, the days-to-cover ratio is currently 2.5 days.

Fresenius Medical Care AG & Co. KGaA Stock Performance

Shares of NYSE:FMS traded up $0.29 on Tuesday, hitting $23.74. 452,683 shares of the company were exchanged, compared to its average volume of 692,838. The company’s 50 day moving average price is $22.25 and its two-hundred day moving average price is $22.84. Fresenius Medical Care AG & Co. KGaA has a one year low of $20.02 and a one year high of $28.86. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.86 and a current ratio of 1.20. The firm has a market capitalization of $12.82 billion, a price-to-earnings ratio of 12.49, a PEG ratio of 4.15 and a beta of 0.80.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) last posted its quarterly earnings data on Tuesday, March 31st. The company reported $1.05 earnings per share (EPS) for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. The company had revenue of $5.34 billion for the quarter. Research analysts expect that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The firm also recently announced an annual dividend, which was paid on Monday, June 8th. Stockholders of record on Friday, May 22nd were given a dividend of $0.8716 per share. This is an increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. The ex-dividend date was Friday, May 22nd. This represents a dividend yield of 402.0%. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio (DPR) is presently 32.11%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. Wall Street Zen downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Citigroup reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, April 24th. Zacks Research downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 27th. Morgan Stanley restated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, May 6th. Finally, Jefferies Financial Group upgraded shares of Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a report on Friday, May 8th. Four equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Strong Sell” and an average price target of $28.00.

Get Our Latest Report on FMS

Institutional Trading of Fresenius Medical Care AG & Co. KGaA

Several institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 50.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 4,135 shares of the company’s stock valued at $93,000 after acquiring an additional 1,383 shares in the last quarter. Royal Bank of Canada boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 479.2% during the 1st quarter. Royal Bank of Canada now owns 216,861 shares of the company’s stock valued at $4,893,000 after acquiring an additional 179,418 shares in the last quarter. Quantinno Capital Management LP boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 15.7% during the 1st quarter. Quantinno Capital Management LP now owns 341,343 shares of the company’s stock valued at $7,701,000 after acquiring an additional 46,428 shares in the last quarter. Sei Investments Co. boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 80.7% during the 1st quarter. Sei Investments Co. now owns 120,704 shares of the company’s stock valued at $2,723,000 after acquiring an additional 53,922 shares in the last quarter. Finally, Cetera Investment Advisers boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 76.7% during the 1st quarter. Cetera Investment Advisers now owns 15,917 shares of the company’s stock valued at $359,000 after acquiring an additional 6,909 shares in the last quarter. 8.37% of the stock is currently owned by institutional investors and hedge funds.

Fresenius Medical Care AG & Co. KGaA Company Profile

(Get Free Report)

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.